Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?

Lily M ParkerKate E BeekmanDanielle K DePaloKelly M EllesonJonathan S Zager

Published in: Journal of surgical oncology (2024)

Further study may identify better prognostic factors for level III positivity, allowing for the possibility of dissecting only levels I and II or even replacing CLND with targeted node dissections.

Keyphrases

prognostic factors
lymph node
sentinel lymph node
neoadjuvant chemotherapy
cancer therapy
prostate cancer
early stage
ultrasound guided
robot assisted
drug delivery